http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2710059-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6517963e19aa5c6b2724ae04212fe2c8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C217-84 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C311-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C237-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C311-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D249-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-84 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D521-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-42 |
| filingDate | 1993-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7648a387c65c178e8deab1da7ef978b7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76f19767fade18d8ad0a7bc0070bc65c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2a5b88848e7ad5981c68308153f0c75 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46efa49007102372661a3593a94a14ac |
| publicationDate | 1995-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | FR-2710059-A1 |
| titleOfInvention | Novel compounds, process for their preparation and their use as medicaments |
| abstract | A compound of formula (I): (CF DRAWING IN BOPI) or a salt thereof, or a solvate thereof, wherein: A and B each independently represent a C1-4 n-alkylene group, in which each carbon atom is optionally substituted with a C1-6 alkyl group; C represents a hydrogen atom, an alkyl, alkenyl or cycloalkyl group; D represents a group CO, SO2, NH-CO or CH2 CO; Z represents a bond, a CH2, (CH2) 2 or X-CH2 CH2 group in which X is an oxygen or sulfur atom; R1, R2 and R3 each independently represent a hydrogen atom, an alkyl, hydroxy or alkoxy group, or if attached to adjacent carbon atoms, any two of R1, R2 and R3 with the carbon atoms to which they are attached can form a condensed heterocyclic ring of 4 to 6 atoms, in which 1, 2 or 3 of these atoms are oxygen or nitrogen atoms: R4 represents an alkylsulfonamido, alkylamido or imidazo group; and Ar represents a substituted or unsubstituted aryl group, in which the optional substituents are the groups R1, R2 and R3 defined above. a process for preparing these compounds, a pharmaceutical composition containing such a compound and the use of such a compound in medicine. |
| priorityDate | 1993-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 64.